Cercar
03/03/2022
High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality
Devereaux, PJ, Lamy, A, Chan, MTV, Allard, RV, Lomivorotov, VV, Landoni, G, Zheng, H, Paparella, D, McGillion, MH, Belley-Cote, EP, Parlow, JL, Underwood, MJ, Wang, CY, Dvirnik, N, Abubakirov, M, Fominskiy, E, Choi, S, Fremes, S, Monaco, F, Urrutia, G, Maestre, M, Hajjar, LA, Hillis, GS, Mills, NL, Margari, V, Mills, JD, Billing, JS, Methangkool, E, Polanczyk, CA, Sant'Anna, R, Shukevich, D, Conen, D, Kavsak, PA, McQueen, MJ, Brady, K, Spence, J, Le Manach, Y, Mian, R, Lee, SF, Bangdiwala, SI, Hussain, S, Borges, FK, Pettit, S, Vincent, J, Guyatt, GH, Yusuf, S, Alpert, JS, White, HD, Whitlock, RP. High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality. NEW ENGLAND JOURNAL OF MEDICINE. 2022; 386(9)DOI:10.1056/NEJMoa2000803. PMID:35235725. IF:158.500(Q1/1D).
02/03/2022
The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey
Simovic, S, Providencia, R, Barra, S, Kircanski, B, Guerra, JM, Conte, G, Duncker, D, Marijon, E, Anic, A, Boveda, S. The use of remote monitoring of cardiac implantable devices during the COVID-19 pandemic: an EHRA physician survey. EUROPACE. 2022; 24(3)DOI:10.1093/europace/euab215. PMID:34410364. IF:6.100(Q1/3D).
01/03/2022
Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials
Garibaldi, M, Nicoletti, T, Bucci, E, Fionda, L, Leonardi, L, Morino, S, Tufano, L, Alfieri, G, Lauletta, A, Merlonghi, G, Perna, A, Rossi, S, Ricci, E, Perez, JA, Tartaglione, T, Petrucci, A, Pennisi, EM, Salvetti, M, Cutter, G, Diaz-Manera, J, Silvestri, G, Antonini, G. Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials. EUROPEAN JOURNAL OF NEUROLOGY. 2022; 29(3)DOI:10.1111/ene.15174. PMID:34753219. IF:5.100(Q1/3D).
01/03/2022
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision (vol 1, pg 3556, 2021)
van den Bergh, PYK, van Doorn, PA, Hadden, RDM, Avau, B, Vankrunkelsven, P, Allen, JA, Attarian, S, Blomkwist-Markens, PH, Cornblath, DR, Eftimov, F, Goedee, HS, Harbo, T, Kuwabara, S, Lewis, RA, Lunn, MP, Nobile-Orazio, E, Querol, L, Rajabally, YA, Sommer, C, Topaloglu, HA. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision (vol 1, pg 3556, 2021). JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2022; 27(1)DOI:10.1111/jns.12479. PMID:. IF:3.800(Q2/4D).